Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Price History
|
Ratios
|
Insiders
Bullboard - Stock Discussion Forum
Virpax Pharmaceuticals Inc (EM)
VRPX
Healthcare
Biotechnology
Virpax Pharmaceuticals, Inc., a preclinical-stage pharmaceutical company, develops various drug-delivery systems and drug-releasing technologies focused on advancing non-opioid and non-addictive pain management treatments for central nervous system disorders. Its preclinical stage product candidates include Epoladerm, a topical spray film delivery technology for osteoarthritis pain; Probudur...
, an injectable local anesthetic liposomal gel technology for postoperative pain management; and Envelta, a nanotechnology-based intranasal spray drug product candidate that enables the delivery of a metabolically labile peptide drug into the brain. The company’s preclinical stage product candidates also include AnQlar, an anti-viral barrier to prevent or reduce the risk or the intensity of viral infections in humans, including influenza and SARS-CoV-2; and NobrXiol, an investigational formulation to be delivered via the nasal route to enhance cannabidiol transport to the brain. Virpax Pharmaceut...
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Bullboard (EXPM:VRPX)
New Post
View:
Posts & Comments
Threaded Posts
(1513)
•••
Iseneschal
X
Post by
Iseneschal
on Nov 22, 2024 8:49am
VRPX...back to back NR's & vol & Price action
Me personally....wouldn't touch this with a 10 Ft pole U do u currently trading at ~ $0.93 on over 33 mil shs
(10)
•••
MikeTester
X
Post by
MikeTester
on Aug 03, 2024 5:01am
Virpax Pharmaceuticals, Inc. (NASDAQ:VRPX): Navigating the C
https://beyondspx.com/2024/08/02/virpax-pharmaceuticals-inc-nasdaqvrpx-navigating-the-challenges-of-a-preclinical-stage-pharmaceutical-company/
How Smart Investors Are Positioning for the Next Innovation Cycle
posted May 13, 2026 9:00am by
Stockhouse Publishing Ltd.
-
|
Gain a sharper edge with data-backed insights into disruptive technologies, innovation trends, and evolving investor opportunities. Explore Episode 1 and discover what could define the next generation of market leaders. ...Learn More
(59)
•••
Nibinator
X
Post by
Nibinator
on Dec 14, 2023 4:35pm
Buy buy buy
Looking fine after market buy at .27
(0)
•••
LinethRamirez
X
Post by
LinethRamirez
on Aug 23, 2021 12:35am
📢📢📣📣📺FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)
(0)
•••
LannieMich23
X
Post by
LannieMich23
on Aug 19, 2021 7:19am
FSD Pharma Inc CEO Anthony Durkacz (Nasdaq: HUGE)(CSE:HUGE)
(1513)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 26, 2021 1:02pm
VRPX....halted x's 3 & NR....on watch
Cheers !
(1513)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 1:16pm
BSQR ..... I'm thinking there will be a P.O announcement
The volume over the past week has been astounding Here is the EDGAR link : EDGAR Entity Landing Page (sec.gov)
(1513)
•••
Iseneschal
X
Comment by
Iseneschal
on Jul 07, 2021 12:23pm
RE:VRPX ....in some here
Flat trdaed a small position..... It showed some promise but failed to deliver No position now.....volume has declined Moving on to VIVE....maybe
(1513)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 12:07pm
VRPX ..... watching for a break of $4.43
if it does ....it's a quick jaunt to $4.63 Just my take. Cheers !
(1513)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 11:53am
VRPX ....in some here
$5.28
(1513)
•••
Iseneschal
X
Post by
Iseneschal
on Jul 07, 2021 11:27am
VRPX .... On watch
Now in PB mode ~$6
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
Featured News Links
MindBio Develops Fatigue Prediction Model using Speech Analytics and AI
Podcasts